2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

The Emerging Landscape of Genotype-Stratified Clinical Trials in Parkinson’s Disease and Atypical Parkinsonian Disorders

YY. Beh, SY. Lim, AM. Abdul Sahak, L. Lange, K. Brolin, A. Noyce, M. Nalls, A. Singleton, H. Morris, AH. Tan (Kuala Lumpur, Malaysia)
The enteric footprint of de novo parkinson’s disease cohort: constipation, inflammation, and nulisa biomarker profiling.

S. Enriquez Calzada, M. Miret Milian, L. Melgarejo, M. Arrué, A. López, S. Belmonte, M. Martinez-Vicente, J. Hernandez-Vara, A. Laguna (Barcelona, Spain)
The epidemiological study of multiple system atrophy beginning in Hokkaido, Japan 2014-2026

M. Matsushima, K. Sakushima, N. Nishimoto, J. Sawada, T. Matsuoka, H. Uesugi, N. Minami, K. Sako, A. Takei, S. Hisahara, Y. Kanatani, A. Tamakoshi, N. Sato, I. Yabe (Sapporo, Japan)
The Evolutionary Pathway of Cognitive Impairment in Parkinson’s Disease: A SuStaIn Study

A. Huang, X. Xue, Z. Wu, S. Liu, E. Xu, P. Chan (Beijing, China)
The Feasibility and Safety of Rehabilitation Program in Patients with Multiple System Atrophy

GY. Lee, S. Cha, S. Jo, J. Lee, M. Choi, SJ. Chung, SH. Lee (Seoul, Republic of Korea)
The Global Parkinsons Genetics Program: Expanding the Diversity of Neurological Disorder Data – 2026 Update

GP2. Global_parkinsons Genetics_program (Bethesda, USA)
The GLP-1 Agonist Paradox in Parkinson’s Disease: A Comparative Analysis of Lixisenatide and Exenatide Phase III Trial Outcomes and Neuroprotective Mechanisms

F. Al-Zaidi (Almaty, Kazakhstan)
The Green Parkinson’s Belt: An Ecological Study of Agricultural Regions Linked to Increased Disease Burden in Mexico

F. Luna-Rangel, B. Gonzalez-Bedolla, S. Robles-Bernal, E. Santiago-Delacruz, D. Rebolledo-Garcia (Monterrey, Mexico)
The Historical Role of Sex and Gender in the History of Access to Movement Disorder Care: A Literature Review

S. Corrick, J. Miyasaki, F. Ba, S. Joza (Edmonton, Canada)
The Impact of Delaying Subcutaneous Device-Aided Therapy for Patients with Advanced Parkinson’s Disease

R. Wiggins, J. Lee, T. Boodhna, O. Yip, J. Homola, L. Pronk, R. van Den Puttelaar, J. Aldred (Charlotte, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z